• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.08% Nasdaq Up0.22%

    ARCA biopharma, Inc. (ABIO)

    -NasdaqCM
    0.98 Up 0.02(2.25%) 11:03AM EST - Nasdaq Real Time Price
    Add to Portfolio
    ProfileGet Profile for:
    ARCA biopharma, Inc.
    11080 CirclePoint Road
    Suite 140
    Westminster, CO 80020
    United States - Map
    Phone: 720-940-2200
    Website: http://www.arcabiopharma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:14

    Business Summary 

    ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on ARCA biopharma, Inc.

    Key Executives 
     PayExercised
    Dr. Michael R. Bristow M.D., Ph.D., 69
    Co-Founder, Chief Exec. Officer, Pres and Director
    402.00K0.00
    Mr. Patrick M. Wheeler , 45
    Chief Financial Officer
    347.00K0.00
    Mr. Christopher D. Ozeroff , 55
    Sr. VP, Gen. Counsel and Sec.
    328.00K0.00
    Mr. Thomas A. Keuer , 55
    Chief Operating Officer
    N/AN/A
    Mr. Brian Selby ,
    Chief Accounting Officer and VP of Fin.
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders